CR-1-31B, a rocaglate-based EIF4A1 inhibitor, potently inhibited osteosarcoma growth in a pulmonary metastasis assay and in experimental and spontaneous models of lung metastasis. The gene discussed is EIF4A1; the disease is osteosarcoma.